AbstractArticle 26.1 of the Cartagena Protocol on Biosafety left open the possibility for member countries to include in their biosafety regulatory processes the assessment of socio‐economic considerations. Countries may also decide to include such assessments as part of their national legislation or regulations for the approval and deliberate release into the environment of genetically engineered technologies. Countries are debating if and how to implement assessment of socio‐economic considerations. This paper contributes to the ongoing policy dialogue by discussing issues related to socio‐economic assessment including scope, timing, inclusion modalities, methods, decision‐making rules and standards, and the integration of socio‐economic assessments in biosafety and/or biotechnology approval processes. This paper also discusses the implications of such inclusion for technology flows and public and private sector R&D. If inclusion is not done properly, it may negatively impact technology flows especially from the public sector and render an unworkable biosafety system.
Meeting the food needs of the world's growing population while reducing poverty and protecting the environment is a major global challenge. Genetically modified crops appear to provide a promising option to deal with this challenge. However there is a need to make strategic decisions on how to spend limited agricultural research funds in order to achieve a maximum impact with regard to finding sustainable solutions to end hunger and poverty. In international development institutions, there is growing interest in the potential use of Strategic Environmental Assessment (SEA) as part of a research based Environmental Management System (EMS) to promote mainstreaming of environmental considerations in policy development. SEA was developed as an approach to integrate environmental considerations at a policy level, where alternatives environmental policies can be evaluated. In this paper, we propose using SEA in a policy research and priority setting process regarding new technologies, taking the development of Genetically Modified Organisms (GMOs) as an example. We propose that this method would be a useful tool for the international agricultural research centers of the Consultative Group for International Agricultural Research (CGIAR), streamlining business processes, strengthening accountability, sharpening the research agenda it supports, fostering broader partnerships, and increasing the relevance and impact of CGIAR research in achieving international development goals. Currently international law requires only Environmental Impact Assessments (EIAs) of specific biotechnology projects. The incorporation of environmental considerations only at the level of specific projects precludes the adoption of alternative environmental policies. In this review, we outline an SEA approach currently being considered at the International Food Policy Research Institute (IFPRI) for use in evaluating biotechnology policies. SEA may be a useful tool to inform the evaluation of biotechnology policies and priorities by taking account of information on the economic, social, and environmental benefits, cost and risks of adopting those policies.-- Authors' Abstract ; Non-PR ; IFPRI1; PBS; Theme 10; GRP34; Subtheme 10.3; Pro-poor science and technology policies ; EPTD
The government of Uganda has already taken steps to evaluate and eventually commercialize genetically modified (GM) cotton. Uganda has drafted a Biotechnology and Biosafety Bill that is currently under parliamentary review. Meanwhile, the biophysical evaluation of insectresistant GM cotton is under way, and the two-year cycle of confined field trials has already been completed. However, a better agronomic performance of GM cotton relative to conventional cotton, under confined trials, may prove to be insufficient reason for decisionmakers to approve GM cotton in Uganda. In fact, the competent Ugandan authorities are now interested in evaluating the benefits of GM cotton adoption for cotton farmers and the overall economy. Although these socioeconomic considerations are not part of the Uganda Biosafety Bill, their implementation is under discussion. ; PR ; IFPRI1; PBS ; EPTD
Tanzania's agriculture faces persistent low crop productivity due to endogenous and exogenous factors, particularly low and unpredictable rainfall, and the incidence of pests. To address these challenges, the government and partners are making efforts to develop and deploy Genetically Modified (GM) Maize varieties with drought tolerance and insect resistant traits (WEMA), and Cassava Brown Streak Disease (CBSD) resistant varieties. This analysis overcomes limitations from earlier assessments of the impacts of those GM crops by accounting for trade-offs in resource competition and considering the indirect effects of adoption and yield gains from GM maize and cassava varieties on the broader economy, the Agri-Food System (AFS), and on household level outcomes. It extends the BioRAPP analysis to an ex-ante economywide framework. We reveal several findings. First, GM maize and cassava (individually and jointly) have positive impacts in the economy, the AFS, and the poverty, particularly in rural areas and among the poorest households. Second, given its relatively greater relevance in output and employment, and the stronger linkages in the AFS, the effects of GM maize on GDP and AFS growth, and poverty is relatively stronger than those from GM cassava. Third, as expected, relatively greater effects are found in higher adoption and high yield gains scenarios, and, in each scenario, the effects on the poorest households are greater than that for the higher quintiles. Furthermore, differential impact across scenarios is also greater amongst the poorest, while the differences are minimal for the top quintile. Finally, the high variation of results across scenarios, and the significant effects of the high adoption/high yield change scenario, suggest that efforts will be critical to ensure the realization of the maximization of adoption rates while ensuring the materialization of the yield growth potential of the GM varieties through the efficient use of technical recommendations on crop production management, and the ...
The International Food Policy Research Institute (IFPRI) published the first method-focused assessment of the applied economic literature about the ex ante and ex post impacts of genetically engineered crops in developing countries in 2009. The overall findings have since been documented by other authors and have been the subject of several other studies and meta-analyses. Of the 154 papers analyzed in the cited IFPRI 2009 publications, only 25 were focused on Africa. Ten years later, this paper shows that the number of publications for Africa has nearly tripled, reaching a total of 72 publications. We gathered, classified, and reviewed all 72 Africa-focused publications. Most of the papers continue to focus on South Africa, an early adopter of the technology and, until 2007, the only African country that had commercialized GE crops. Today, even after the commercialization of insect resistant crops in Burkina Faso, Egypt, and Sudan, and the recent approval for commercialization of insect resistant cotton in Nigeria and Ethiopia, South Africa continues to be the most represented country in the literature and is the focus of 30 of the 72 publications. Nevertheless, a shift is occurring. Whereas only 4 African countries were represented in 2006, there are now 24. Additionally, the crop-focus of this literature has also expanded from mainly cotton to include a wider variety of crop/technologies, such as bacillus thuringiensis (Bt)/nutritionally enhanced banana, Bt tomato, and drought-resistant maize, among others. In addition to documenting and analyzing this Africa-focused literature, this paper documents a total of 353 performance indicators related to the actual or projected changes in yields, gross income, and input use contained in the papers focus of this review. A summary of these performance indicators has also been compiled as a searchable database available to all potential users, including practitioners, interested decision and policy makers, as well as businesses and donors not only to facilitate further research, but also as reference to advance specific GE policies, and to increase awareness related to GE technology performance. ; Non-PR ; IFPRI1; CRP2; 1 Fostering Climate-Resilient and Sustainable Food Supply ; EPTD; PIM; DGO ; CGIAR Research Program on Policies, Institutions, and Markets (PIM)
The Government of Uganda has implemented programs and policies to improve the agricultural sector's recent underperformance. Uganda's two main food security crops, bananas and cassava, have been critically affected by two diseases: Banana Xanthomonas Wilt (BXW) and Cassava Brown Streak Disease (CBSD). The effectiveness of agronomic and cultural practices to control these diseases has been limited, requiring better alternatives. The Ugandan R&D sector in collaboration with international partners have developed genetically engineered innovations that can control both diseases. To examine the potential benefits to consumers and producers from the adoption of genetically engineered banana and cassava with resistance to BXW and CBSD, we use a set of economic impact assessment methods. These include an economic surplus model implemented via IFPRI's DREAMpy framework, a real options model and a limited gender assessment. Results from the economic surplus approach suggest that the adoption of both technologies can benefit Uganda. These results were confirmed for the case of bananas and partially for the case of cassava using the real options and the gender assessment performed. Results from this assessment are predicated on Uganda maintaining an enabling environment that will ensure the deployment and use of both innovations. Looking forward, continuing to improve enabling environment for innovation in Uganda will require addressing current R&D, regulatory, technology deployment and product stewardship processes constraints.
This paper uses an innovative research process to quantify the potential impacts of releasing and adopting insect-resistant (IR) cowpea and nitrogen-use efficient (NUE) rice in Ghana using an economic surplus partial equilibrium model. The premise of the research process was to build national capacity to produce timely and robust estimates, based on secondary data and qualified experts' informed opinions, collected in country. Ghana's stakeholders selected the two genetically modified (GM) technologies discussed here based on their assessment of these GM products' regulatory advancement and their economic and political importance. Using assumptions regarding the expected changes from the adoption and commercialization of these crops, collected from national and international crop and technology experts, the authors estimate that the benefits of adopting IR cowpea are between US$5.5 million and US$125.3 million, and between US$1.9 million and US$153 million for NUE rice. The analysis also shows how a five-year regulatory delay may erode these benefits, reducing them by between 29 and 39 percent for IR cowpea and between 28 and 57 percent for NUE rice. Additionally, the authors make preliminary estimates of sex-disaggregated benefits and calculate the unequal distribution of benefits between female and male producers and consumers owing to gender disparities in production and consumption. The welfare estimations are based on an economic surplus model that were estimated using the DREAM software. Although this partial equilibrium model has limitations regarding market-clearing assumptions and is specific to a product, it is a data-parsimonious method that can produce results in a short time frame, which might better suit policymakers' and decision makers' demands for rapid estimations. ; Non-PR ; IFPRI1; DCA; CRP2; 4 Transforming Agricultural and Rural Economies; Capacity Strengthening; BioRAPP ; EPTD; PIM ; CGIAR Research Program on Policies, Institutions, and Markets (PIM)
The Government of Uganda has implemented programs and policies to improve the agricultural sector's recent underperformance. Uganda's two main food security crops, bananas and cassava, have been critically affected by two diseases: Banana Xanthomonas Wilt (BXW) and Cassava Brown Streak Disease (CBSD). The effectiveness of agronomic and cultural practices to control these diseases has been limited, requiring better alternatives. The Ugandan R&D sector in collaboration with international partners have developed genetically engineered innovations that can control both diseases. To examine the potential benefits to consumers and producers from the adoption of genetically engineered banana and cassava with resistance to BXW and CBSD, we use a set of economic impact assessment methods. These include an economic surplus model implemented via IFPRI's DREAMpy framework, a real options model and a limited gender assessment. Results from the economic surplus approach suggest that the adoption of both technologies can benefit Uganda. These results were confirmed for the case of bananas and partially for the case of cassava using the real options and the gender assessment performed. Results from this assessment are predicated on Uganda maintaining an enabling environment that will ensure the deployment and use of both innovations. Looking forward, continuing to improve enabling environment for innovation in Uganda will require addressing current R&D, regulatory, technology deployment and product stewardship processes constraints. ; Non-PR ; IFPRI1; CRP2; DCA; 1 Fostering Climate-Resilient and Sustainable Food Supply; 2 Promoting Healthy Diets and Nutrition for all; Capacity Strengthening; BioRAPP ; EPTD; PIM ; CGIAR Research Program on Policies, Institutions, and Markets (PIM)
"Local farming communities throughout the world face productivity constraints, environmental concerns, and diverse nutritional needs. Developing countries address these challenges in a number of ways. One way is public research that produces genetically modified (GM) crops and recognize biotechnology as a part of the solution. To reach these communities, GM crops, after receiving biosafety agreement, must be approved for evaluation under local conditions. However, gaps between approvals in the developed and developing world grow larger, as the process of advancing GM crops in developing countries becomes increasingly difficult. In several countries, only insect resistant cotton has successfully moved from small, confined experimental trials to larger, open trials and to farms. By far, most GM crop approvals have been for commercial products that perform well under tropical conditions. However, complete information on public GM crop research in developing countries has not been assessed. "Will policies and research institutions in the developing world stimulate the safe use of publicly funded GM food crops?" The relatively few GM crops approved from public research, coupled with growing regulatory, biosafety capacity, trade, and political concerns, argue to the contrary. To tackle this issue, we identified and analyzed public research pipelines for GM crops among 16 developing countries and transition economies. Respondents reported 209 genetic transformation events for 46 different crops at the time when the survey was conducted. The pipelines demonstrate scientific progress among publicly funded crop research institutes in participating countries. Information and findings are presented for GM crops nearing final stages of selection. Additional details are provided for the types of genes and traits used, the breadth of genetic resources documented, implications for regulation, and the type of research partnerships employed. Regulations, GM crop approvals, choice of transgene, and policy implications are discussed as they affect this research. Based on these findings, recommendations are presented that would help sustain and increase efficiency of publicly supported research while meeting biosafety requirements. To do so, the study examines results concerning investments and choices made in research, capacity, and policy development for biotechnology. These indicate the risk and potential for GM technologies in developing countries. Policy makers, those funding biotechnology, and other stakeholders can use this information to prioritize investments, consider product advancement, and assess relative magnitude of potential risks, and benefits." -- Authors' Abstract ; Non-PR ; IFPRI1; Theme 10; Subtheme 10.1; GRP1; PBS; Pro-poor science and technology policies ; EPTD; ISNAR
